582 related articles for article (PubMed ID: 10560813)
1. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
[TBL] [Abstract][Full Text] [Related]
2. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
Zhang J; Tao LJ; Ning JP; Xu H; Ai YH; Zhao SP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):81-4. PubMed ID: 14764220
[TBL] [Abstract][Full Text] [Related]
3. [The effect of continuous high-volume hemofiltration therapy on TNF-alpha of pancreatitis patients complicated with acute renal function failure].
Li ZJ; Xu YQ; Wang HM; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jul; 19(4):373-5. PubMed ID: 15163389
[TBL] [Abstract][Full Text] [Related]
4. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.
Klouche K; Cavadore P; Portales P; Clot J; Canaud B; Béraud JJ
J Nephrol; 2002; 15(2):150-7. PubMed ID: 12018631
[TBL] [Abstract][Full Text] [Related]
5. [Opportunity for treatment of acute renal failure after cardiac vascular operation using continuous blood purification].
Mei YQ; Li Q; Wang XS; Feng J; Cai JZ; Sun YF; Xie SL; Li DW; Hu DY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2144-6. PubMed ID: 19080479
[TBL] [Abstract][Full Text] [Related]
6. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital.
Chuasuwan A; Gojaseni P; Chittinandana A
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459
[TBL] [Abstract][Full Text] [Related]
7. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release.
Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Atti M
ASAIO J; 1992; 38(1):52-4. PubMed ID: 1313318
[TBL] [Abstract][Full Text] [Related]
8. Transfer of endogenous pyrogens across artificial membranes?
Lonnemann G; Linnenweber S; Burg M; Koch KM
Kidney Int Suppl; 1998 May; 66():S43-6. PubMed ID: 9573572
[TBL] [Abstract][Full Text] [Related]
9. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.
Heering P; Morgera S; Schmitz FJ; Schmitz G; Willers R; Schultheiss HP; Strauer BE; Grabensee B
Intensive Care Med; 1997 Mar; 23(3):288-96. PubMed ID: 9083231
[TBL] [Abstract][Full Text] [Related]
10. [Tumor necrosis factor-alpha kinetics during renal replacement therapy in patients with sepsis and multiple organ failure].
Timokhov VS; Iakovleva II; Kalashnikova EA; Semenov VN
Ter Arkh; 1997; 69(11):38-9. PubMed ID: 9483744
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
[TBL] [Abstract][Full Text] [Related]
13. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.
Mariano F; Fonsato V; Lanfranco G; Pohlmeier R; Ronco C; Triolo G; Camussi G; Tetta C; Passlick-Deetjen J
Nephrol Dial Transplant; 2005 Jun; 20(6):1116-26. PubMed ID: 15814541
[TBL] [Abstract][Full Text] [Related]
14. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock.
Rogiers P; Zhang H; Pauwels D; Vincent JL
Crit Care Med; 2003 Apr; 31(4):1219-25. PubMed ID: 12682496
[TBL] [Abstract][Full Text] [Related]
15. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of coupled plasma filtration adsorption combined with continuous veno-venous hemofiltration for multiple organ dysfunction syndrome patients with acute liver failure].
He CS; Shi W; Ye ZM; Liang XL; Zhang B; Liu SX; Qin TH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):47-9. PubMed ID: 17207366
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
Ghani RA; Zainudin S; Ctkong N; Rahman AF; Wafa SR; Mohamad M; Manaf MR; Ismail R
Nephrology (Carlton); 2006 Oct; 11(5):386-93. PubMed ID: 17014550
[TBL] [Abstract][Full Text] [Related]
18. [Effect of continuous veno-venous hemofiltration on the plasma level of cytokines in patients with multiple organ dysfunction syndrome].
Kou QY; Chen J; Ouyang B; Guan XD
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1197-9. PubMed ID: 17147866
[TBL] [Abstract][Full Text] [Related]
19. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
[TBL] [Abstract][Full Text] [Related]
20. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
